FARMINGDALE, NY, — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well. “In […]
Amerigo Scientific recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. New York, United States – Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. The new […]
Six new products that can be used to detect residual host cell genomic DNA (gDNA) Manassas, VA, and Rockville, MD, United States — Today, ATCC and U.S. Pharmacopeia (USP), two premier materials management and standards organizations, announced the launch of their first set of joint products to advance the quality control and reduce the risk in the […]
New licence provides CHUM access to the ERS CRISPR/Cas9 patent portfolio. DUBLIN and MONTREAL — ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with the CHUM Research Centre (‘(CRCHUM),’). This is a non-exclusive licensing agreement granting the CRCHUM research rights to the ERS CRISPR/Cas9 patent portfolio. Dr. Emmanuelle Charpentier, founder of ERS Genomics, received the […]
INDIANAPOLIS and PLEASANTON, Calif. – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a new partnership to expand automation solutions for single cell assay workflows. As part of the agreement, 10x Genomics plans to develop […]
Partnership covers development of lab-developed and distributable kit-based companion diagnostic tests Combined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion diagnostic solutions based on PCR, digital PCR (using the QIAcuity system), and NGS Future projects may include advanced analysis and accessibility of measurable residual disease (MRD) and homologous […]
Oxford, UK – OGT, A Sysmex Group Company and leading global provider of clinical research solutions, and Intelliseq, a genome informatics company, are delighted to announce the release of GeneSpect™ Somatic Reporter for use with OGT’s SureSeq™ portfolio of next generation sequencing (NGS) panels. This advanced analytical reporting solution pairs state-of-the-art variant interpretation and reporting with […]
This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications. OXFORD, United Kingdom — Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Saphetor, the next generation sequencing data analysis company, today announce a new […]
Company appoints Jon Murray as VP Sales, Colleen McMillen as VP Marketing, and Dave Anstey as VP Pharma Business Development Ann Arbor, MI — Genomenon®, Inc., a leading genomic intelligence company, has announced new executive appointments for its sales and marketing team as the company continues to expand its footprint across clinical diagnostics and pharmaceutical markets. These […]
SANTA CRUZ, CA, USA — “We are honored to have someone of Mikael’s caliber join our team,” said RealSeq Biosciences CEO, Sergio Barberan-Soler, Ph.D. “His expertise will be invaluable as we continue to develop innovative solutions for the growing field of RNA fragmentomics and novel biomarker strategies.” Mikael Kubista, Ph.D. is a world-renowned expert in gene expression and qPCR analysis. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
